Form 8-K - Current report:
SEC Accession No. 0001437749-21-021587
Filing Date
2021-09-08
Accepted
2021-09-07 19:03:15
Documents
13
Period of Report
2021-09-01
Items
Item 2.01: Completion of Acquisition or Disposition of Assets

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bioli20210907_8k.htm   iXBRL 8-K 22179
  Complete submission text file 0001437749-21-021587.txt   153669

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA blfs-20210901.xsd EX-101.SCH 3592
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blfs-20210901_def.xml EX-101.DEF 11423
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE blfs-20210901_lab.xml EX-101.LAB 15309
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blfs-20210901_pre.xml EX-101.PRE 11583
6 EXTRACTED XBRL INSTANCE DOCUMENT bioli20210907_8k_htm.xml XML 2579
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

EIN.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36362 | Film No.: 211240418
SIC: 3845 Electromedical & Electrotherapeutic Apparatus